129 related articles for article (PubMed ID: 22534467)
1. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
Sun LL; Sun XX; Xu XE; Zhu MX; Wu ZY; Shen JH; Wu JY; Huang Q; Li EM; Xu LY
Acta Histochem; 2013 Jan; 115(1):56-62. PubMed ID: 22534467
[TBL] [Abstract][Full Text] [Related]
2. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
[TBL] [Abstract][Full Text] [Related]
3. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract][Full Text] [Related]
4. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast.
Zhao LH; Liu HG
Genet Mol Res; 2015 May; 14(2):5417-26. PubMed ID: 26125737
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.
Wang L; Mao Y; Du G; He C; Han S
Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457
[TBL] [Abstract][Full Text] [Related]
9. JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.
Kuo YT; Liu YL; Adebayo BO; Shih PH; Lee WH; Wang LS; Liao YF; Hsu WM; Yeh CT; Lin CM
PLoS One; 2015; 10(5):e0125343. PubMed ID: 25951238
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
12. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
Huang YQ; Zou Y; Zheng RJ; Ma XD
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
[TBL] [Abstract][Full Text] [Related]
14. [The effects of JARID1B siRNA on proliferation and apoptosis in HL-60 cell].
Ma XD; Han HD; Huang YQ; Zou Y
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):392-6. PubMed ID: 22781799
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the transcription repressor PLU-1/JARID1B.
Scibetta AG; Santangelo S; Coleman J; Hall D; Chaplin T; Copier J; Catchpole S; Burchell J; Taylor-Papadimitriou J
Mol Cell Biol; 2007 Oct; 27(20):7220-35. PubMed ID: 17709396
[TBL] [Abstract][Full Text] [Related]
16. Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):188-92. PubMed ID: 25789538
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma.
Liu HC; Zhang Y; Wang XL; Qin WS; Liu YH; Zhang L; Zhu CL
Biomed Pharmacother; 2013 Oct; 67(8):751-5. PubMed ID: 23725757
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
19. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
20. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]